No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Buy Rating Justified by Q32 Bio's Promising Pipeline and Market Potential
Express News | Q32 Bio Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $54
Q32 Bio (QTTB) Gets a Buy From Oppenheimer
Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
Express News | Q32 Bio Reports Q1 2024 GAAP EPS Of $(6.33)
Q32 Bio | 10-Q: Quarterly report
No Data